MedPath

US THROMBOTIC MICROANGIOPATHY ALLIANCE

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Impact of Acute ITTP Therapies on Long Term Neurologic and Cognitive Outcomes in ITTP Survivors

Not yet recruiting
Conditions
Immune Thrombotic Thrombocytopenia
Interventions
First Posted Date
2024-04-10
Last Posted Date
2024-11-13
Lead Sponsor
US Thrombotic Microangiopathy Alliance
Target Recruit Count
116
Registration Number
NCT06358703
Locations
🇺🇸

USTMA, Groveport, Ohio, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.